Arixtra - supply shortage

Resolved

fondaparinux sodium

Shortage information

The shortage affecting Arixtra has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Arixtra
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  fondaparinux sodium
• Therapeutic area (MESH):
  • Venous Thrombosis
  • Pulmonary Embolism
  • Myocardial Infarction
  • Angina, Unstable
• Pharmaceutical forms affected:
  Pre-filled syringe
• Strengths affected:
  • 1.5 mg
  • 2.5 mg
  • 5.0 mg
  • 7.5 mg
• Availability of alternatives:
  Yes

Key dates

• First published:
  07/07/2017
• Last updated:
  21/03/2018